Immuno-Oncology Advances in Applied Cellular Analysis - 25

Advances in Applied Cellular Analysis * Continuous Live-Cell Analysis of the Immune-Tumor Axis

ClearView plates and monitored for migration
via phase-contrast images (10x) collected automatically every 30 min for 24h using IncuCyte.
Addition of CXCL12 (3-200nM) in the basechamber caused clear concentration, and timedependent chemotaxis; higher concentrations
caused more rapid movement than lower concentrations and the measured EC50 was 23nM.
No directional migration was observed with
vehicle control or the inactive chemokine,
CXCL11 (100nM). Co-addition of the CXCR-4
receptor antagonist AMD3100 abolished the
response to CXCL12. Similar observations were
made with the human T-cell line, Jurkat. In four
assay plates run in parallel, the Z' values for the
high and low control groups ranged from 0.5-0.8
and CXCL12 EC 50 values from 19-33nM,
indicating high assay precision and
reproducibility. From the time-lapse videos,
the movement of individual T-cells through
the pores could be clearly observed.

Summary
For each of the immuno-oncology examples
provided, IncuCyte® CLCA yielded robust,
25

| GENengnews.com

Figure 7 (C & D).
Scale bar 100μM. (C) Note the time-and
SDF-1α concentration-dependent
chemotactic cell migration quantified as
a reduction in cell area on the topside of
the plate. (D) Concentration response
curves for SDF-1α obtained from
four separate experiments illustrates
assay reproducibility.


http://www.GENengnews.com

Immuno-Oncology Advances in Applied Cellular Analysis

Table of Contents for the Digital Edition of Immuno-Oncology Advances in Applied Cellular Analysis

Contents
Immuno-Oncology Advances in Applied Cellular Analysis - 1
Immuno-Oncology Advances in Applied Cellular Analysis - 2
Immuno-Oncology Advances in Applied Cellular Analysis - 3
Immuno-Oncology Advances in Applied Cellular Analysis - Contents
Immuno-Oncology Advances in Applied Cellular Analysis - 5
Immuno-Oncology Advances in Applied Cellular Analysis - 6
Immuno-Oncology Advances in Applied Cellular Analysis - 7
Immuno-Oncology Advances in Applied Cellular Analysis - 8
Immuno-Oncology Advances in Applied Cellular Analysis - 9
Immuno-Oncology Advances in Applied Cellular Analysis - 10
Immuno-Oncology Advances in Applied Cellular Analysis - 11
Immuno-Oncology Advances in Applied Cellular Analysis - 12
Immuno-Oncology Advances in Applied Cellular Analysis - 13
Immuno-Oncology Advances in Applied Cellular Analysis - 14
Immuno-Oncology Advances in Applied Cellular Analysis - 15
Immuno-Oncology Advances in Applied Cellular Analysis - 16
Immuno-Oncology Advances in Applied Cellular Analysis - 17
Immuno-Oncology Advances in Applied Cellular Analysis - 18
Immuno-Oncology Advances in Applied Cellular Analysis - 19
Immuno-Oncology Advances in Applied Cellular Analysis - 20
Immuno-Oncology Advances in Applied Cellular Analysis - 21
Immuno-Oncology Advances in Applied Cellular Analysis - 22
Immuno-Oncology Advances in Applied Cellular Analysis - 23
Immuno-Oncology Advances in Applied Cellular Analysis - 24
Immuno-Oncology Advances in Applied Cellular Analysis - 25
Immuno-Oncology Advances in Applied Cellular Analysis - 26
Immuno-Oncology Advances in Applied Cellular Analysis - 27
https://www.nxtbookmedia.com